Figure 3.
Serum ceramides (Cer) in post-OLT patients. C14Cer (A), C18Cer (B) and C18:1Cer (C) are up-regulated in patients with current tacrolimus intake, compared to no tacrolimus intake (* p < 0.05).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.